<DOC>
	<DOCNO>NCT00744393</DOCNO>
	<brief_summary>The purpose study determine effect sodium oxybate function sleep mechanically ventilate , critically ill patient hospitalize intensive care unit .</brief_summary>
	<brief_title>The Effect Sodium Oxybate Sleep Architecture</brief_title>
	<detailed_description>Sleep disrupt critically ill may lead impaired neurocognitive function , decrease immune function , increase protein catabolism , may compromise ability wean patient mechanical ventilation . Critically ill patient may appear sleep throughout stay , quality sleep different normal healthy subject.Critically ill patient spend time wakefulness stage sleep ( Stage 1 2 ) expense restorative stage ( Stage 3 4 ) REM sleep . These patient also experience increased number arousal awakening . Various factor think cause abnormal sleep architecture : ICU environment , pain , illness severity , psychosocial stress , medication , mechanical ventilation . Sodium oxybate ( Xyrem® ) sodium salt central nervous system depressant γ-hydroxybutyric acid ( GHB ) currently approve use narcoleptic patient improve cataplexy excessive daytime sleepiness . Studies evaluate use sodium oxybate narcoleptic patient suggest sodium oxybate effective increase slow-wave sleep , sleep efficiency , sleep latency , REM-sleep efficiency , also decrease REM-sleep latency , stage 1 NREM sleep sleep fragmentation.3 , 16-19 Currently lack data evaluate effect sodium oxybate sleep critically ill patient . Obtaining evidence sodium oxybate improves sleep architecture critically ill , may provide foundation complete future study evaluate effect sodium oxybate clinical outcome duration mechanical ventilation length ICU stay . Based sodium oxybate 's ability improve sleep architecture narcoleptic patient along fact critically ill patient similar disrupt sleep architecture , 's postulated sodium oxybate may improve sleep architecture critically ill patient .</detailed_description>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Age ≥ 18 year Mechanically ventilate ≥ 24º AC mode Placement enteral gastric tube ( Note : tube place exclusively purpose study . ) Tolerating enteral nutrition via either stomach small intestine ( ≥20mL/hr ≥ 12 hour ) Anticipated duration mechanical ventilation ≤72º ( per MICU team estimate ) Riker SAS ≤ 2 ( determine patient 's nurse and/or study investigator ) History irreversible brain disease consistent severe dementia base MICU service admission note Admitted primary neurological condition ( e.g . intracranial hemorrhage ) History seizure disorder intracranial surgery History myocardial infarction prior 6 month Pregnancy ( woman child bear potential undergo serum pregnancy test prior study consent ) Administration schedule benzodiazepine either continuous drip give IVP Acute alcohol withdrawal AST/ALT &gt; 2 time ULN , INR &gt; 2 T bilirubin &gt; 1.5 Current prior use sodium oxybate past 30 day . Hypernatremia serum sodium &gt; 150 Current use follow hypnotic : barbiturate , melatonin , zolpidem , eszopiclone , zaleplon Use neuromuscular block agent Allergy sodium oxybate Known succinic semialdehyde dehydrogenase deficiency History periodic limb movement disorder . A prognosis consider hopeless ( per MICU team ) Inability obtain informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>sleep</keyword>
	<keyword>critically ill</keyword>
	<keyword>mechanical ventilation</keyword>
</DOC>